We have partnered with international experts to provide rare bone diseases highlights from ASBMR 2021.
This is the second in a series of four podcasts. In this episode Dr Oliver Semler has selected and discusses his highlights.
Do you know how to differentiate between growth hormone deficiency (or GHD) and primary IGF-I deficiency (or growth hormone resistance) and the key challenges...
In this first episode of a three-episode podcast series, COR2ED and ASBMR have partnered with Professor Anna Teti (University of L’Aquila) to provide rare...
How are advances in radioligand therapy shaping the treatment of neuroendocrine tumours, and what does recent trial evidence tell us? What are the key...